Safinamide
Product Specifications
CAS Number
133865-89-1
Target
MAO, Monoamine Oxidase, Sodium Channel
Related Pathways
Neuroscience, Metabolism, Membrane transporter/Ion channel
Purity
0.9992
Bioactivity
Safinamide (FCE-26743) is a reversible and selective monoamine oxidase B (IC50 0.098μM) inhibitor, reducing the degradation of dopamine, and a glutamate release inhibitor (IC50 8μM) . It also inhibits dopamine reuptake. Safinamide also blocks sodium and calcium channels. Potential additional uses of Safinamide might be Parkinson's disease, restless leg syndrome and epilepsy.
Smiles
O(CC1=CC(F)=CC=C1)C2=CC=C(CN[C@H](C(N)=O)C)C=C2
Molecular Formula
C17H19FN2O2
Molecular Weight
302.34
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A138717 100 µL
PE-conjugated Anti-CCR8 (10A11) Biosimilar (Monoclonal, IgG1)
Sign In for Pricing
View Details HP516046-01 5 mg
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501)
Sign In for Pricing
View Details HP516046-02 10 mg
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501)
Sign In for Pricing
View Details